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Obtaining the full microbial potential to
beneﬁt local communities and citizens,
as well as ongoing conservation efforts,
is a major challenge for Brazil and other
developing countries. We propose poli-
cies and priorities for organizing micro-
biome studies locally and worldwide,
aiming for a comprehensive catalogue of
microbiomes, as recently urged.
Microorganisms are recognized as a fun-
damental resource for creating a fast and
efﬁcient strategy for ecosystem manage-
ment and scientiﬁc and technological
development. Microbial community
assembly and functions are tightly linked
to local geographic and environmental
features [1]. Developing countries, such
as Brazil, house biomes evolving under
speciﬁc environmental conditions that
likely harbor unique microbiomes. Chal-
lenges in proﬁling microbial diversity
include a lack of standardized methods
and metadata collection that precludes
robust interstudy comparisons, limiting
the value of these studies [2–4]. Advances
in sequencing technologies and associ-
ated bioinformatics approaches should
now enable comparison of the diversity,
abundance, and function of microbial
communities at much greater resolution
than was previously possible [5]. Recently,
three papers have pointed to the need for
microbiome research coordination [4,6,7].
These proposals envisioned guidelines forintellectual-property rights, research prior-
ities for funding (including a long-term
interagency funding strategy), the devel-
opment of new analytical tools, training
programs, data integration through an
in-country distributed data center and pol-
icies on data sharing. We argue here that
there is a need for developing local lead-
ership in microbiome research [8] and
propose establishing an initiative to foster
international collaborations in order to
marshal microbiome research in Brazil.
Recently, the US government, along with
the private sector, has announced a sig-
niﬁcant budget to launch the National
Microbiome Initiative (NMI) [9]. Consider-
ing geography as an important part of the
microbiome puzzle, the development of
local initiatives will strengthen the NMI
and provide a basis for a global micro-
biome effort [6].
In 2008, the Brazilian Ministry of Science
and Technology consolidated an impor-
tant strategy to restructure policies of sci-
entiﬁc development, implementing the
National Institutes of Science and Tech-
nology (INCT in Portuguese). The main
objectives of the INCT are to strengthen
national research, increase training, inter-
nationalize groups, and transfer knowl-
edge to society, business sectors, and
government when appropriate. Despite
a direct relationship with the strategic
themes established by public policies of
the Brazilian government, the systematic
study of microbiomes and their biotech-
nological potential remain limited. We
have proposed a systematic study of Bra-
zil's microbial resources as a valuable
new focus area for the INCT efforts.
Although pressed by the economic
slump, political crisis, and their conse-
quences for science and technology
[10], Brazil is moving forward on micro-
biome research. The National Council of
Technological and Scientiﬁc Develop-
ment (CNPq) has recommended the cre-
ation of a National Institute of Science
and Technology to advance microbial
research–the INCT Microbiomei. During
the next months, a combined evaluationTby the CNPq and other Brazilian agencies
supporting research, such as CAPES,
FINEP and FAPESP (São Paulo Research
Foundation), will forge a deﬁnitive agree-
ment for assembling this institute, poten-
tially awarding it a budget of up to 10
million Brazilian Reais (US$ 2.8 million).
The INCT Microbiome aims to be a center
of international excellence seeking to
coordinate and provide guidance to
microbiome researchers, besides bal-
ancing inequality of research opportuni-
ties in Brazil. Low- and middle-income
countries are usually prevented from per-
forming state-of-the-art microbiome
research due to a lack of structure or to
a lack of well-trained people. Local initia-
tives might beneﬁt from a core center
housing all the necessary infrastructure
and trained scientists, to provide high-
quality project design, cutting-edge tech-
nology (sample processing, sequencing,
etc.) and training on data analyses to
deliver the best solutions to collaborators.
The beneﬁts brought by such an
endeavor will be essential to consolidate
the local initiative envisioned to advance
Brazilian microbial studies [8]. We hope
that this initiative can serve as a template
for leadership of microbiome research in
other developing countries.
The Brazilian Microbiome Project (BMP)ii
[11] was set up in 2013, and this will form
the basis for the INCT Microbiome. Now,
Brazil is expected to advance on it, uniting
microbiome investigators to support the
development of an unprecedented knowl-
edge base of microbial resources. In
2012, Brazil moved forward in the assess-
ment and use of biodiversity by joining the
Global Biodiversity Information Facility
(GBIF) and by creating the Biodiversity
Portaliii in 2015. However, microbial infor-
mation has been ignored, as has hap-
pened in previous attempts to explore
biological resources in Brazil [12]. A new
database is required to combine Brazilian
microbial data with other biodiversity data,
including GBIF, and in agreement with the
Brazilian laws of biodiversity data sharing
(normative instruction 02/2015 of therends in Microbiology, October 2016, Vol. 24, No. 10 767
Chico Mendes Institute for Biodiversity
Conservation–ICMBio).
Four key issues have been identiﬁed as
priorities for scientiﬁc research: (i) standard-
ization of methods and integration with
existing groups developing protocols and
standards, such as the Earth Microbiome
Project (EMP)iv, TerraGenomev and QIITAvi,
to ensure that studies are systematic and
comparable, allowing the development of a
dynamic and constantly expanding data-
base that can provide real-time information
for all users; (ii) characterizing microbiomes
under natural conditions, which is of
fundamental importance for establishingPlant mic
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bial interventions that allow the mainte-
nance of the quality and productivity of
the environment or host; and (iv)
develop/expand partnership among aca-
demic studies, agriculture, medicine, and
industry. This well-deﬁned approach is
expected to increase the understanding
of Brazil's microbial resources with the goal
of developing strategies to: mitigate envi-
ronmental pollution; increase the activity of
beneﬁcial microorganisms from soils; sup-
press pathogenic microorganisms in plants
and humans; and create an efﬁcient strat-
egy for scientiﬁc and technological biopro-
specting. To achieve these goals, the INCTBioinform
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 INCT Microbiome. Broken lines represent possible futureMicrobiome needs to be inherently collab-
orative. We propose an organizational
model that represents speciﬁc scientiﬁc
research domains, and strategic commit-
tees focused on training and transfer of
knowledge and technology (Figure 1).
Research domain committees will be the-
matic, addressing microbial interactions
with plants, animals, soils, aquatic environ-
ments, and humans as well as on biopro-
specting. Each theme will consider
research drivers, scan the horizon, and
translate research into socioeconomic rel-
evance. Promising translational areas
include the effects of pollution and land
use change, improving agriculturalacs
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Box 1. Primary Habitats and Hosts Currently Being Addressed by the INCT Microbiome Collaborators
A microbiome is deﬁned as ‘the entire habitat, including the microbes (bacteria, archaea, lower and higher eukaryotes, and viruses), their genomes (i.e., genes), and the
surrounding environmental conditions’ [14]. Megadiverse countries represent promising scenarios for biotechnological advances, which can be enhanced by the local
researcher's microbiome consortia. A catalogue of targets for microbial prospection, permeating the entire Brazilian territory, ranging from agricultural improvements to
human health promotion, is provided below as an example:
(i) Microbiomes associated with plants
 The microbiome of wheat cultivars and their ancestors: many microorganisms associated with roots can beneﬁt plants on nutrition and tolerance to biotic and
abiotic stress factors. For over a century, breeders have explored plant genes to improve their performance and productivity, but the rhizosphere microbiome
has been neglected. Exploring the microbiome of wheat cultivars and their ancestors will allow for the development of new approaches applying microorganisms
to sustainably improve plant development and health.
 The microbiome of sugarcane: plants seek the help of microbesEvidence suggests that plants under attack ‘ask for help’ from the microbiome and actively
recruit beneﬁcial microbes for their health. As a result, soil becomes suppressive to diseases. Characterizing the microbiome of sugarcane with contrasting levels
of resistance might contribute to empowering biological control through speciﬁc microbe activities.
(ii) Microbiomes associated with animals
 The cattle's intestinal and skin microbiome: ruminants’ microbiomes are now being explored as sources of biomass-degrading enzymes to be applied in the
industrial production of biofuels. Also, tick susceptibility in cattle has now been related to volatile compounds produced by speciﬁc skin microbiome proﬁles,
making its modulation a hopeful strategy for promoting resistance to ectoparasites. The comparisons of microbiomes of different cattle breeds, in different
geographical regions and subject to different management practices, will allow veriﬁcation of the degree of contribution of genetic makeup and the environment.
The knowledge generated will enable the development of innovative and sustainable technologies for tick control, such as probiotics and/or repellents.
 Intestinal microbiota associated with productivity performance in broiler chickens: the use of antibiotics in animal feed as growth promoters has resulted in
increased susceptibility to enteric diseases and dysbiosis, and caused a negative effect on the productivity of broiler chickens. Research has shown various
beneﬁcial effects of using probiotics, prebiotics, symbiotic, organic acids and plant extracts in the diets of birds. The sum of the results of these studies will allow
the nutritionist to adopt optimized feeding strategies, in order to modulate the intestinal microbiota of broiler chickens for higher performance.
(iii) Microbiomes associated with soils
 Microbiomes of mangrove soils: mangroves are highly productive and have a rich associated biodiversity. They are subject to constant anthropic impacts, which
are the main cause of deterioration of these ecosystems. This line of research seeks to access the microbiome of mangrove soils of the North, Northeast,
Southeast, and Southern regions of Brazil, correlating them with environmental variables to better understanding the microbial taxonomy and functioning in
mangroves.
 Microbiome of Caatinga biome soils (arid soils): the Caatinga biome suffers constant limitations related to water deﬁcit. In recent years, aridity of the Caatinga has
been increasing due to human activities, resulting in increased erosion of soils, microclimate changes, and desertiﬁcation. Obtaining information regarding the
effects of these habitats on the diversity and function of the microbial community is essential to guide sustainable recovery practices for this biome. At the same
time, this region is a promising target to unravel novel strategies of plant drought resistance mediated by microbes.
 Microbiome of agricultural soils: deﬁning the organizing principles that control the assembly of soil microbial communities under land-use change will help to
provide the basis to understand how individual microbes and microbial communities function in response to changing environmental parameters (at a molecular
scale) and vice versa. Microbial-community-mediated biological processes will be linked to environmental parameters, allowing us to build predictive models of
metabolic and regulatory processes related to the changes caused by agriculture and adopting strategies for mitigating global heating.
(iv) Microbiomes associated with aquatic environments
 Characterizing the microbiome of water and sediments of the rivers and water reservoirs: environmental pollution is also an important issue, and initiatives to
mitigate it are highly important to preserve rivers and water reservoirs. Increasing anthropogenic activity can lead to ecological imbalance of water bodies and the
extinction of key microbial species. A comprehensive metagenomic study correlating the microbiome and the trophic conditions allow for proposing solutions for
improving the quality of water available in the reservoirs.
(v) Microbiomes associated with human health
 Biocontrol of human vector-borne diseases: in the tropics, several emerging maladies and vector-borne viral diseases have the potential to cause epidemics,
such as malaria, dengue fever, chikungunya, and more recently the Zika virus. Combating these vectors and pathogenic agents is somehow ineffective by
traditional approaches, but novel interventions such as the introduction of a Wolbachia strain in Aedes aegypti has reduced the infection with dengue,
chikungunya, and Zika viruses as well as Plasmodium parasites. Biological control and its ecological implications are promising for solving public health issues.
 Association among fetal microbiota, prematurity, and preterm morbidities: the biological causes for preterm deliveries remain poorly deﬁned. Multiple lines of
evidence indicate that the microbiome in expectant mothers can trigger premature delivery. Identifying such a mechanism would have important implications for
designing nutritional interventions in pregnant mothers aimed at establishing a microbiota with lower risk for preterm delivery.
(vi) Bioprospecting
 One of the most promising approaches for the discovery of new bioactive compounds is the use of metagenomics in the search for new biosynthetic genes for
cloning and expression in a heterologous or homologous host. Bioprospecting allows for the development of new biotechnological sustainable processes
related to bioremediation, bioreﬁning, mining bioleaching, oil recovery, or cleaning of oil storage tanks, based on the isolation of microorganisms capable of
performing these functions.
(vii) Bioinformatics
 Data analysis and pipelines: computational resources can be difﬁcult to handle, and the effective execution and reproducibility of analyses is a challenge given the
amount and nature of the data. Metagenomic analyses have been described as one of the least reproducible NGS applications, mainly due to the lack of
integrated and standardized solutions. The recent development of standard methods and protocols allowed proper data analysis and interpretation. Up to now,
this initiative provided the community with a web platform for data analysis, a Linux-based Operational System dedicated to data analyses and standard
methods, and data analyses pipelinesii. More than 10 000 users from 112 countries (most from Brazil, the USA, and the UK) have already beneﬁted.
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practices, water treatment and manage-
ment, animal breeding, and microbial
effects on human health (Box 1 gives for
a detailed list of primary targets in Brazil).
Expanding capacity in bioinformatics is
critical because the current bottleneck
for biosciences is how to analyze ‘big data’
[4,13]. In-depth analysis of the growing
number of completely sequenced micro-
bial genomes in public databases is pro-
viding fascinating contributions to our
understanding of how microbes are genet-
ically tailored to their lifestyles. The quality
of this information critically depends on
high-quality genome annotation. Accurate
annotation is challenging, and perhaps
even more important to new understand-
ing of microbes than the development of
new sequencing technologies. For exam-
ple, mobile genomic elements (MGEs) are
important for pathogenicity and antibiotic
resistance, but are often poorly under-
stood because they are not well anno-
tated. To address the annotation and
other related issues, an effective Bioinfor-
matics Committee should be assembled to
support satellite bioinformatics laborato-
ries for training collaborative teams. This
effort is paramount to improve data inter-
pretation and reproducibility, and to foster
the development of new protocols to meet
the demands of a diverse group of collab-
orators. Studies of microbiomes in partic-
ular are under-funded in Brazil, and ties to
international efforts and to industry will be
important for developing appropriate bio-
informatics techniques.
A Committee for Knowledge Transfer is
essential to integrate all other groups and
to link university/research institutions and
society. In addition to providing resources
for improving basic education, local lead-
erships will make scientiﬁc knowledge
accessible to all, transferring information
generated by the different research
groups to society. Intellectual property
(IP) issues represent a major concern for
developing countries, and the improve-
ment of already established IP organiza-
tions should be addressed. Strong IP770 Trends in Microbiology, October 2016, Vol. 24, No. 10protection systems beneﬁt the country's
economy by attracting investors and fos-
tering innovation. The restricted budget of
such countries reﬂects the lack of IP
expertise hindering patent deposition. In
agreement with the recently approved
Congressional Law Project (PLC) 77/
2015, which regulates long-term partner-
ships between the public and private sec-
tors in Brazil, local activities allow better
integration of scientiﬁc data with entrepre-
neurs. Eliminating these bureaucratic
obstacles promotes innovation and tech-
nological advances for exploring Brazilian
biodiversity. The challenge here includes
the creation of a ‘one-stop shopping ser-
vice’ providing a single point of contact
between public and private sectors, capa-
ble of addressing individual challenges, to
offer both sides the most appropriate IP
solutions. Protecting the particular inter-
ests of traditional societies (e.g., indige-
nous people) and sharing the beneﬁts
generated from the use of traditional
knowledge in biotechnological develop-
ment fairly is also an important and ongo-
ing discussion, now supported by the
Brazilian Biodiversity Law 13.123/2015
and its recent regulatory decree.
We urge support of the integrative solu-
tions proposed here, through the creation
of the INCT Microbiome. This local micro-
biome initiative will not only address the
Brazilian problems of imbalance of micro-
biome studies and data fragmentation,
but will serve as a model helping to guide
future interagency funding efforts world-
wide, besides ensuring appropriate proj-
ect alignment with other international
efforts [6,7]. We aim to empower local
research to solve our problems at home,
generating knowledge and technology to
further address global questions.
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Spotlight
Antibiotic
Methylation: A New
Mechanism of
Antimicrobial
Resistance
Kerri M. Malone1 and
Stephen V. Gordon1,2,3,4,*
In new research on Mycobacterium
tuberculosis, the causative agent
of tuberculosis, Warrier and col-
leagues have discovered a novel
mode of bacterial drug resistance,
namely antibiotic inactivation via
N-methylation.By 2050, 10 million lives a year and a
cumulative US$100 trillion of economic
output are at risk due to the rise of
drug-resistant infectionsi. Tuberculosis
(TB) represents just one of the infectious
diseases that we must ﬁnd new ways to
control if this trend is to be halted and
reversed. TB kills someone every
25 seconds, a shocking statistic that
makes Mycobacterium tuberculosis one
of the deadliest pathogens on the planet
[1]. M. tuberculosis was one of the ﬁrst
pathogens to be identiﬁed as the aetio-
logical agent of an infectious disease by
Robert Koch in 1882. Bacillus Calmette–
Guérin (BCG), the TB vaccine, is the most
widely used vaccine in the world, given toover 100 million children every year, while
cheap, effective drugs are available for
treatment of drug-sensitive infections.
So why does TB continue to exact such
a heavy toll of morbidity and mortality?
Control of TB is complicated by the unique
biology of M. tuberculosis, the variable
efﬁcacy provided by the BCG vaccine to
protect those immunized against disease,
restricted healthcare access for those
affected, HIV coinfection, and prolonged
drug therapy that is driving the emergence
of drug resistance [1]. It is predicted that
over 2 billion people harbor latent M.
tuberculosis infection, providing a vast
reservoir of infection [1]. These hurdles
have not, however, limited the vision of
TB-control policies with the World Health
Organization (WHO) End TB Strategy
seeking to end the global TB epidemic
by 2035 through achieving a 95% decline
in TB deaths and a 90% reduction in dis-
ease incidence as compared to 2015ii.
Delivery of this vision will need progress
on multiple fronts, and will hinge on the
development of new anti-TB drugs.
The drugs currently available for the
treatment of TB are mainly the products
of antibiotic discovery efforts in the
1940s–1960s. Only since the declaration
of TB as a global public health emer-
gency by the WHO in 1993 did the TB
drug development pipeline sputter back
to life. However, decades of neglect,
increased regulations, and a lack of inter-
est from pharmaceutical companies has
meant that the pipeline contains a mere
trickle of new compounds; further
research is desperately needed to iden-
tify novel drug candidates and to unravel
drug-resistance mechanisms of the TB
bacillus.
Investigations into the antimycobacterial
properties of imidazopyridine- and pyr-
ido[1,2-/]benzimidazole-containing com-
pounds have shown that these
compounds are active against M. tuber-
culosis, and against multidrug-resistant
(MDR)- and extensively drug resistantT(XDR)-TB clinical isolates [2–5]. Through
the characterization of one such com-
pound containing a pyrido-benzimidazole
core designated ‘14’ [4], Warrier et al.
have described an entirely novel mode
of drug resistance for bacteria, namely
inactivation of an antibiotic via N-methyl-
ation [6].
To elucidate the mode of action of ‘14’,
Warrier and colleagues isolated multiple
M. tuberculosis clones resistant to the
compound. Whole-genome sequencing
of these clones identiﬁed 16 unique can-
didate resistance-conferring mutations,
with nine of these mutations mapping to
the rv2887 gene alone [6]. The Rv2887
protein belongs to the MarR family of
transcription factors, with the resis-
tance-conferring mutations predicted to
affect the ability of Rv2887 to bind DNA.
Binding assays showed that Rv2887
bound directly to the promoter region
upstream of rv0560c, a gene encoding
a putative methyltransferase. rv0560c
was found to be expressed at 400-fold
higher levels in resistant M. tuberculosis
clones than in sensitive wild-type M.
tuberculosis, while exposure of wild-type
M. tuberculosis to ‘14’ caused consistent
upregulation of rv0560c expression.
Based on these ﬁndings it was deduced
that Rv2887 was a negative regulator of
rv0560c expression, with resistance-
conferring mutations in rv2887 found to
inhibit the ability of the Rv2887 transcrip-
tion factor to bind DNA, resulting in the
upregulated expression of rv0560c in
resistant clones [6].
The role of Rv0560c in resistance of M.
tuberculosis to ‘14’ was next explored.
As it was reported that Rv0560c was
nonessential to the survival of M. tuber-
culosis [7], it was unlikely that Rv0560c
was the target of ‘14’ but rather that its
enzymatic activity must render ‘14’ inac-
tive in some manner. Characterization of
the methyltransferase activity of recom-
binant Rv0560c showed that it directly
methylated ‘14’ at the N-5 position, lead-
ing to the loss of 14's antimycobacterialrends in Microbiology, October 2016, Vol. 24, No. 10 771
